No single mood stabilizer stands out as the universal best choice for anxiety, because the right one depends on whether your anxiety exists alongside bipolar disorder, appears as treatment-resistant generalized anxiety, or reflects something else entirely. That said, quetiapine, lamotrigine, and valproate each have meaningful evidence behind them for different anxiety-related scenarios, and the research landscape has some genuine surprises. The picture also shifts depending on your sex, your age, and whether pregnancy is a consideration.
Why Mood Stabilizers Enter the Anxiety Conversation at All
Most people think of SSRIs or benzodiazepines when they hear “anxiety medication.” Mood stabilizers occupy a different mental category, one associated with bipolar disorder and seizure control. But the overlap between mood disorders and anxiety is enormous. A large meta-analysis found that roughly 43% of people with bipolar disorder have a lifetime history of at least one anxiety disorder, with panic disorder, generalized anxiety, and social anxiety each showing up in 13 to 17% of those patients.1The Lancet. Prevalence of Comorbid Anxiety Disorders in Bipolar Disorder: A Systematic Review and Meta-analysis – Section: Results That means close to half the people prescribed a mood stabilizer are also dealing with clinically significant anxiety. For many of them, treating the mood instability with the right stabilizer can relieve both problems at once.
There’s also a growing body of evidence for using certain mood stabilizers in people with treatment-resistant generalized anxiety disorder who don’t have bipolar disorder at all. A review of the literature on treatment-resistant GAD identified two medication classes with the most supporting data: GABA-related agents (which include valproate) and atypical antipsychotics (which include quetiapine).2PubMed Central. Management of treatment-resistant generalized anxiety disorder So the question isn’t just academic for people with bipolar disorder. It matters for anyone whose anxiety hasn’t responded to first-line treatments.
Quetiapine and Generalized Anxiety
Of all the medications typically classified as mood stabilizers or mood-stabilizer-adjacent, quetiapine has the most robust trial data for generalized anxiety disorder as a standalone condition. A meta-analysis of randomized controlled trials found that quetiapine monotherapy reduced anxiety symptoms at rates comparable to SSRIs, with the 50 mg and 150 mg extended-release doses showing significantly better response and remission rates than placebo.3PubMed Central. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials – Section: Results That’s a striking result: a medication best known for treating psychotic symptoms and bipolar mania performing on par with the gold-standard antidepressants for everyday anxiety.
An individual trial reinforced this, showing that quetiapine XR at 150 mg per day produced significant improvement in anxiety scores by day four, faster than most SSRIs typically take to kick in.4International Clinical Psychopharmacology. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study For people stuck in a severe anxiety episode, that speed matters. A maintenance study also found that people who stabilized on quetiapine XR had an 81% lower risk of anxiety symptom recurrence compared to those switched to placebo.5International Clinical Psychopharmacology. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder
So why isn’t quetiapine the default anxiety medication? Side effects. Quetiapine commonly causes sedation, weight gain, and metabolic changes that can increase the risk of diabetes over time. For someone whose anxiety is mild and responds to an SSRI, those trade-offs don’t make sense. Quetiapine tends to be reserved for cases where first-line options have failed or where a person also has bipolar symptoms that need managing.
Lamotrigine for Anxiety With Depression
Lamotrigine is a different kind of mood stabilizer. Where lithium and valproate act heavily through the brain’s main inhibitory signaling system (GABA), lamotrigine works primarily by dialing down glutamate, the brain’s main excitatory chemical, and it has some GABA-enhancing effects as well.6PubMed Central. Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution – Section: Abstract This dual action is thought to explain why it’s especially effective against the depressive side of bipolar disorder and seems to help with anxiety that rides alongside depression.
Controlled trial data specifically targeting lamotrigine for anxiety are limited, but the clinical evidence is encouraging. A long-term study of lamotrigine across all types of bipolar disorder found that treatment benefits appeared by week four and were sustained through a full year.7PubMed Central. Long-term efficacy and safety of lamotrigine for all types of bipolar disorder – Section: RESULTS Case reports add texture: one documented case involved a woman with chronic depression and anxiety who had failed three different antidepressants and a benzodiazepine before switching to lamotrigine, which finally brought meaningful relief.8PubMed Central. The effectiveness of lamotrigine for persistent depressive disorder: A case report – Section: Abstract
Clinicians often gravitate toward lamotrigine for people whose primary struggle is depressive episodes peppered with anxiety, rather than pure mania or pure generalized anxiety. Its side-effect profile is lighter than quetiapine’s in terms of weight gain and metabolic risk, which makes it easier to tolerate long-term. The main risk to watch for is a rare but serious skin reaction that can occur in the first weeks, which is why the dose is always increased very gradually.
Valproate and the GABA Connection
Valproate (often prescribed as divalproex sodium) is one of the older mood stabilizers, and its anxiety-relevant properties come from how it boosts GABA signaling in the brain. It slows the breakdown of GABA, letting more of it accumulate and exert its calming influence.9Translational Psychiatry. Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial – Section: Discussion This is a different route from benzodiazepines, which amplify the signal that existing GABA sends. The net effect on the nervous system is calming in both cases, but the mechanisms aren’t identical, and this may explain why some people respond to valproate after benzodiazepines haven’t worked.
In one study of patients with panic disorder and mood instability who hadn’t responded to conventional treatment, all ten subjects showed significant improvement in both anxiety and depressive symptoms after starting divalproex sodium, along with reductions in panic attacks and better quality of life.10PubMed. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy – Section: RESULTS That’s a small study, so the numbers shouldn’t be taken as population-level proof, but the direction of the findings lines up with animal research showing that valproate produces measurable anti-anxiety effects in behavioral tests.11PubMed Central. Anxiolytic and sedative effects of sodium valproate with different experimental paradigms in male and female rats – Section: GENERAL DISCUSSION
The animal research is worth mentioning for another reason: it found that the anti-anxiety effect showed some sex-dependent variation, with female rats responding at certain doses where males didn’t. Whether this translates to humans is unknown, but it’s a reminder that biological sex can influence how well a medication works, something that is still under-studied in psychiatric pharmacology.
Valproate’s downsides include potential liver toxicity, weight gain, and hair thinning. It also requires periodic blood tests to monitor drug levels and liver function, which adds a layer of inconvenience that lamotrigine and quetiapine don’t share to the same degree.
When Anxiety Is Actually Bipolar Disorder in Disguise
One of the most consequential reasons mood stabilizers come up in the anxiety conversation has nothing to do with treating anxiety directly. It has to do with misdiagnosis. People in the depressive phase of bipolar disorder often experience intense anxiety, and if a clinician only sees the depression and anxiety, they may prescribe an antidepressant without a mood stabilizer. That can go badly. Treating bipolar disorder with antidepressants alone is not effective and can trigger hypomania, full mania, or rapid cycling between mood states.12PubMed. Strategies to reduce misdiagnosis of bipolar depression
If you’ve been treated for anxiety and depression and your symptoms keep shifting, worsening, or taking on new flavors you can’t explain, the possibility of an underlying bipolar spectrum condition is worth raising with your provider. In those cases, the “best” mood stabilizer for your anxiety isn’t really a treatment for anxiety per se. It’s the correct treatment for the actual condition driving the anxiety. And getting that diagnosis right matters far more than choosing between drug A and drug B.
Side Effects and Tolerability Across Options
All mood stabilizers come with side-effect profiles that require active management. These range from cognitive effects and gastrointestinal symptoms to metabolic, hormonal, and neurological complications. Most side effects are either temporary or dose-related, meaning they can be managed by finding the lowest effective dose.13PubMed. Management of adverse effects of mood stabilizers But some rare reactions are serious enough to require stopping the medication immediately.
In practice, the tolerability differences between these drugs often drive the choice more than the efficacy differences do. A rough comparison:
- Quetiapine: Sedation and weight gain are the most common complaints. Metabolic monitoring (blood sugar, cholesterol) is recommended. The sedation can actually be helpful for people whose anxiety disrupts sleep, but it can also interfere with daytime functioning.
- Lamotrigine: Generally the best tolerated of the group. The main concern is the rare skin reaction in early treatment, which means slow dose titration is mandatory. Weight effects are minimal compared to the others.
- Valproate: Requires blood monitoring, can cause weight gain and tremor, and has significant risks in pregnancy. It’s also associated with hair thinning, which bothers some people enough to switch medications.
- Lithium: Not covered in depth here because its evidence for anxiety specifically is weaker, but it’s worth noting that lithium withdrawal itself can produce anxiety, irritability, and sleep disruption, symptoms that sometimes get confused with a relapse of the original condition.14PubMed Central. Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder
Pregnancy Changes the Calculus Significantly
If you’re pregnant or planning a pregnancy, the ranking of these medications shifts. An umbrella review in Molecular Psychiatry found that lithium during the first trimester was associated with roughly double the odds of cardiac and congenital malformations, though the absolute risk remains low.15PubMed Central. Safety of psychotropic medications in pregnancy: an umbrella review – Section: Mood stabilisers Valproate is widely considered the most teratogenic mood stabilizer and is generally avoided during pregnancy whenever possible.
A network meta-analysis comparing multiple agents found that quetiapine had the lowest teratogenic risk among the commonly used options, followed closely by lamotrigine and haloperidol. Lamotrigine did not show a statistically significant increase in congenital malformations compared to unexposed pregnancies.16PubMed Central. Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes – Section: Results / Conclusions For a person who needs a mood stabilizer during pregnancy and also struggles with anxiety, lamotrigine and quetiapine are generally the options that clinicians feel most comfortable continuing, though every situation requires an individualized risk-benefit conversation.
Combining Medication With Therapy
Medication alone rarely tells the full story. A randomized controlled study found that people with bipolar disorder who received cognitive behavioral group therapy alongside their medication had fewer symptoms of mania, depression, and anxiety compared to those on medication alone. They also experienced fewer mood episodes and shorter ones.17Brazilian Journal of Psychiatry. The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study – Section: Results This isn’t surprising, but it’s important to state plainly: if you’re on a mood stabilizer and still feeling anxious, adding structured therapy is one of the strongest evidence-based moves you can make.
This is especially relevant because anxiety in bipolar disorder feeds on behavioral patterns like avoidance, sleep disruption, and catastrophic thinking, all of which therapy can target directly in ways that medication cannot. The medication calms the neurochemistry; the therapy restructures the habits and thought patterns that keep anxiety alive between episodes.
How These Drugs Act on the Brain Differently
One reason there’s no single “best” mood stabilizer for anxiety is that these drugs work through different brain pathways, and different types of anxiety may respond to different pathways. Valproate and quetiapine both increase GABA’s influence in the brain, but they do so through different mechanisms. Valproate reduces the enzymatic breakdown of GABA, effectively leaving more of it available.18PubMed. Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity Quetiapine’s anxiolytic action is more complex and involves serotonin and norepinephrine pathways in addition to GABA-related ones. Lamotrigine, as noted earlier, works primarily by reducing glutamate release rather than boosting GABA.
A randomized controlled trial directly comparing the anxiety-related effects of valproate and pregabalin found that both reduced experimentally induced anxiety in humans, but through distinct GABA-related mechanisms. The study highlighted that even within a single neurotransmitter system, the specific point of intervention matters for the clinical result.9Translational Psychiatry. Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial – Section: Discussion This is why a person who doesn’t respond to one GABA-enhancing drug might still respond to another: they’re not all pressing the same button.
What Happens When You Stop
Discontinuing a mood stabilizer is not just a matter of whether your anxiety comes back. The withdrawal process itself can create anxiety symptoms that weren’t there before. Literature on lithium discontinuation, for instance, documents anxiety, irritability, and sleep disturbances as withdrawal effects, symptoms that overlap heavily with the conditions the drug was treating in the first place.14PubMed Central. Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder This makes it genuinely hard to tell whether a person who feels worse after stopping medication is relapsing or experiencing withdrawal, and it’s one reason clinicians prefer gradual tapers over abrupt stops.
If you’re considering stopping a mood stabilizer because your anxiety feels managed, the withdrawal question is worth discussing with your prescriber before making changes. In many cases, the medication is doing more than you can feel, and the anxiety you’ve forgotten about has a way of reappearing once the chemical support is pulled away.